{
    "2021-12-21": [
        [
            {
                "time": "2021-12-01",
                "original_text": "Broadway League president on Omicron spike: 'We don’t anticipate being shut down at any time soon’",
                "features": {
                    "keywords": [
                        "Omicron",
                        "spike",
                        "shut down"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "entertainment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-02",
                "original_text": "3 Healthcare Stocks to Buy If You're Worried About a Market Crash",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "Market Crash"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-03",
                "original_text": "Novavax CEO: 'We will be filing within the next few days with FDA'",
                "features": {
                    "keywords": [
                        "Novavax",
                        "FDA",
                        "filing"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-04",
                "original_text": "Novavax (NVAX) COVID Vaccine Gets EU Nod, 2nd Listing by WHO",
                "features": {
                    "keywords": [
                        "Novavax",
                        "EU",
                        "WHO",
                        "vaccine"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-05",
                "original_text": "Stocks rebound after Omicron concerns rattle markets",
                "features": {
                    "keywords": [
                        "Stocks",
                        "rebound",
                        "Omicron",
                        "markets"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-06",
                "original_text": "COVID-19: What the Biden administration is doing to address winter surge in cases",
                "features": {
                    "keywords": [
                        "Biden",
                        "administration",
                        "winter surge",
                        "cases"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-07",
                "original_text": "Glaxo (GSK) Gets FDA Nod for HIV Preventive Injectable Drug",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "FDA",
                        "HIV",
                        "drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-08",
                "original_text": "Novavax CEO: ‘We are making an Omicron variant strain vaccine’",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Omicron",
                        "vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-09",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson & Johnson, Home Depot, Toyota, Oracle and Intuit",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Johnson & Johnson",
                        "Home Depot",
                        "Toyota",
                        "Oracle",
                        "Intuit"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diverse sectors"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-10",
                "original_text": "UPDATE 2-Blood thinner drug Xarelto tied to higher rate of major side effects - study",
                "features": {
                    "keywords": [
                        "Xarelto",
                        "side effects",
                        "study"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-11",
                "original_text": "COVID-19: U.S. confirms first death linked to Omicron variant",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "U.S.",
                        "death",
                        "Omicron"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-12",
                "original_text": "Moderna (MRNA) COVID-19 Booster Jab Effective Against Omicron",
                "features": {
                    "keywords": [
                        "Moderna",
                        "booster",
                        "Omicron"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-13",
                "original_text": "Omicron surge: Live event cancellations are ‘still a minority,’ Vivid Seats CEO says",
                "features": {
                    "keywords": [
                        "Omicron",
                        "surge",
                        "cancellations",
                        "Vivid Seats"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "entertainment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-14",
                "original_text": "Blood thinner drug Xarelto tied to more major side-effects - study",
                "features": {
                    "keywords": [
                        "Xarelto",
                        "side-effects",
                        "study"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Coronavirus: White House to distribute 500M at-home COVID tests amid Omicron surge",
                "features": {
                    "keywords": [
                        "White House",
                        "at-home tests",
                        "Omicron"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-16",
                "original_text": "UPDATE 1-German committee recommends booster after three months as Omicron spreads",
                "features": {
                    "keywords": [
                        "German",
                        "committee",
                        "booster",
                        "Omicron"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-17",
                "original_text": "DYAI: Jumpin’ Janssen Jamboree",
                "features": {
                    "keywords": [
                        "DYAI",
                        "Janssen",
                        "Jamboree"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}